 Bronchodilator beta-adrenergic agents acute stable COPD COPD beta-agonist bronchodilators ill COPD patients similar improvements pulmonary function drug responses patients stable Patients ipratropium bromide micrograms metaproterenol sulfate mg MDI delivery device study Ninety minutes first medication patients second Spirometry entry intervals first drug times second drug Results follow groups clinical characteristics groups airway obstruction entry study study ipratropium significant improvement mean increase percent change crossover study ipratropium similar improvements minutes mean increase percent improvement crossover metaproterenol study improvement different ipratropium mean increase percent improvement crossover study improvement metaproterenol significant similar mean increase percent ipratropium metaproterenol pulmonary function COPD patients stable acute exacerbations